Caforio Giovanni 4

Accession 0000014272-24-000052

CIK 0000014272other

View on SEC.gov Company Profile

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 5:42 PM ET

Size

28.9 KB

Accession

0000014272-24-000052

Insider Transaction Report

Form 4

Period: 2024-03-10

BRISTOL MYERS SQUIBB COBMY

Caforio Giovanni

Pres., US Pharmaceuticals

Transactions

Tax Payment
Common Stock, $0.10 par value
2024-03-10$53.79/sh−10,088$542,634→ 377,129.333 total
Tax Payment
Common Stock, $0.10 par value
2024-03-10$53.79/sh−47,651$2,563,147→ 432,266.333 total
Exercise/Conversion
Market Share Units
2024-03-10−23,817→ 23,818 total
Exp: 2025-03-10→ Common Stock, $0.10 par value (23,817 underlying)
Other
Market Share Units
2024-03-10−22,214→ 44,429 total
Exp: 2026-03-10→ Common Stock, $0.10 par value (22,214 underlying)
Other
Market Share Units
2024-03-10−23,419→ 70,258 total
Exp: 2027-03-10→ Common Stock, $0.10 par value (23,419 underlying)
Exercise/Conversion
Performance Shares
2024-03-10−142,904→ 0 total
Exp: 2024-03-10→ Common Stock, $0.10 par value (142,904 underlying)
Other
Common Stock, $0.10 par value
2024-03-10−3,687→ 387,217.333 total
Exercise/Conversion
Common Stock, $0.10 par value
2024-03-10+23,817→ 400,946.333 total
Tax Payment
Common Stock, $0.10 par value
2024-03-10$53.79/sh−10,084$542,418→ 386,758.333 total
Exercise/Conversion
Common Stock, $0.10 par value
2024-03-10+142,904→ 529,662.333 total
Other
Common Stock, $0.10 par value
2024-03-10−49,745→ 479,917.333 total
Exercise/Conversion
Market Share Units
2024-03-10−23,409→ 0 total
Exp: 2024-03-10→ Common Stock, $0.10 par value (23,409 underlying)
Exercise/Conversion
Common Stock, $0.10 par value
2024-03-10+23,409→ 390,904.333 total
Other
Common Stock, $0.10 par value
2024-03-10−4,104→ 396,842.333 total

Footnotes (12)

[F1]Represents vesting of one-quarter of market share units granted on March 10, 2020.
[F10]Twenty-five percent of these market share units will vest on each of the first, second, third and fourth anniversaries of the grant date.
[F11]Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved.
[F12]Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.
[F2]Adjustment reflects shares disposed upon the vesting of market share units due to the performance factor.
[F3]Shares withheld for payment of taxes upon vesting of awards.
[F4]Represents vesting of one-quarter of market share units granted on March 10, 2021.
[F5]Amount represents distribution of performance shares earned under the 2020-2022 Long-Term Performance Award.
[F6]Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board.
[F7]Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
[F8]Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.
[F9]Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved.

Documents

1 file

4
wk-form4_1710279706.xmlPrimary
FORM 4

Issuer

BRISTOL MYERS SQUIBB CO

CIK 0000014272

→

Entity typeother

Related Parties

filerCIK 0001533201

Filing Metadata

Form type: 4
Filed: Mar 11, 8:00 PM ET
Accepted: Mar 12, 5:42 PM ET
Size: 28.9 KB

View on SEC.gov